# Short Read Sequencing Market

> Short Read Sequencing Market Research Report: Size, Share, Trend Analysis By Applications (Clinical diagnostics, Agrigenomics, Oncology, Genomics Research, Molecular Biology), By Technology (Illumina sequencing, Ion Torrent sequencing, SOLiD sequencing, SMRT sequencing), By End Use (Academic research institutes, Pharmaceutical companies, Biotechnology companies, Hospitals and clinics), By Product Type (Sequencing kits, Sequencing services, Sequencing instruments) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 19.2%
- **2024:** $ 9.48 Billion
- **2025:** $ 11.31 Billion
- **2035:** $ 65.49 Billion
- **Key Players:** Illumina (US), Thermo Fisher Scientific (US), BGI Genomics (CN), Roche (CH), Qiagen (DE), Oxford Nanopore Technologies (GB), Pacific Biosciences (US), Agilent Technologies (US), Genomatix (DE)

**Report ID:** MRFR/HC/20278-HCR · **Pages:** 128 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** May 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/short-read-sequencing-market-21876

---

## Market Summary

## **Short Read Sequencing Market Overview**

As per MRFR analysis, the Short Read Sequencing Market Size was estimated at 7.07 (USD Billion) in 2023.
The Short Read Sequencing Market Industry is expected to grow from 7.71(USD Billion) in 2024 to 20 (USD Billion) by 2035. The Short Read Sequencing Market CAGR (growth rate) is expected to be around 9.05% during the forecast period (2025 - 2035).

### **Key Short Read Sequencing Market Trends Highlighted**

The Short Read Sequencing Market is growing quickly because genomic technologies are becoming better and more uses are being found in personalized medicine, cancer research, and infectious disease research. The falling cost of sequencing technologies is a major factor driving the market. This makes them easier for research institutes and healthcare providers to acquire. Also, the desire for precision medicine is speeding up the use of short-read sequencing since it lets researchers execute genome-wide investigations faster and more accurately. There are several possibilities to look into, such as using artificial intelligence and machine learning in data analysis.

This might make sequencing findings easier to understand and more useful, which could lead to new ways to improve clinical diagnosis and treatment plans.

Recent developments in the worldwide market show that there is a rise in partnerships between the public and commercial sectors to improve sequencing technology and its uses. Many governments are working to promote genomics research and make it easier for institutions to share more data. This is leading to greater innovation and faster results in genomic investigations. 

The development of genomic data creation has also led to a rise in demand for sequencers that can handle massive amounts of data. Also, the emphasis on non-invasive diagnostic procedures is making people increasingly interested in liquid biopsies, which use short-read sequencing to find changes in the DNA of circulating tumors.

 Overall, these new developments will help the Global short-read sequencing Market thrive. Researchers will keep putting money into it, and it will keep growing as they look for new ways to study genetics.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Short Read Sequencing Market Drivers**

### **Increasing Demand for Personalized Medicine**

The Short Read Sequencing Market Industry is significantly driven by the rising demand for personalized medicine, which tailors treatment based on individual genetic profiles. A report from the National Institutes of Health indicates a surge in the adoption of genomic information in clinical settings, with over 80% of medical institutions integrating genetic data into patient management plans.

Organizations such as Illumina have spearheaded initiatives to transform genomic data into actionable healthcare insights, leading to breakthroughs in treating complex diseases like cancer and rare genetic disorders.With the projected demand for personalized treatments expected to rise by upwards of 15% annually, the evolution of tailored medication is creating robust growth potential for the Short Read Sequencing Market, allowing for enhanced patient outcomes and customized therapies.

### **Advancements in Sequencing Technologies**

The rapid advancements in sequencing technologies, particularly High Throughput Sequencing, are propelling the Short Read Sequencing Market Industry forward. The FDA reported a remarkable improvement in sequencing accuracy and throughput, which has facilitated the exploration of genomic sequences at an unprecedented scale. Companies like Thermo Fisher Scientific are heavily investing in Research and Development to enhance sequencing platforms, increasing output levels by approximately 50% over the last five years.

Such advancements not only minimize the cost per base of sequencing but also accelerate research timelines, capturing significant interest from both academia and biotechnology firms, further catalyzing market growth.

### **Rising Incidence of Genetic Disorders**

The increasing incidence of genetic disorders worldwide is a major driver for the Short Read Sequencing Market Industry. According to the World Health Organization, genetic disorders affect approximately 10% of the global population, with about 300 million people suffering from rare diseases. This alarming statistic underlines the urgent need for effective diagnostics, where short-read sequencing techniques serve as a crucial tool in understanding and diagnosing these conditions.Organizations such as the Global Genes Project are raising awareness and promoting research in this field, paving the way for innovative genome mapping techniques.

Consequently, the demand for accurate and efficient sequencing solutions is projected to grow, fundamentally supporting the market's expansion.

## **Short Read Sequencing Market Segment Insights**

### **Short Read Sequencing Market Application Insights**

The Short Read Sequencing Market under the Application segment showcases a robust growth trajectory with revenue expected to reach 7.71 USD Billion by 2024 and 20.0 USD Billion by 2035. The market is significantly driven by various key applications including Clinical diagnostics, Agrigenomics, Oncology, Genomics Research, and Molecular Biology, each playing a crucial role in enhancing healthcare and scientific research worldwide.

Among these applications, Clinical diagnostics emerges as a major driving force, holding a valuation of 2.5 USD Billion in 2024 and growing to 6.4 USD Billion by 2035, underscoring its pivotal role in patient care and disease management.Agrigenomics also commands attention with projections of 1.7 USD Billion in 2024 rising to 4.2 USD Billion by 2035, reflecting the increasing demand for genetic analysis in agriculture to improve crop yields and resistance.

Oncology, valued at 1.8 USD Billion in 2024 and expected to reach 4.6 USD Billion by 2035, is particularly vital as it offers techniques for the early detection and targeted treatment of various cancers, thus significantly impacting patient outcomes.

Moreover, Genomics Research is projected to grow from 1.3 USD Billion in 2024 to 3.3 USD Billion by 2035, highlighting its importance in unlocking genetic information that could lead to breakthroughs in personalized medicine.Lastly, Molecular Biology, albeit with a smaller valuation of 0.41 USD Billion in 2024, is anticipated to increase to 1.5 USD Billion by 2035, emphasizing its foundational role in understanding biological processes and advancements in biotechnology.

The collective contributions of these applications illuminate the market dynamics, as advancements in sequencing technologies drive innovation and adoption across multiple domains, benefiting areas such as diagnostics, therapeutic development, and agricultural enhancements. With substantial Short Read Sequencing Market statistics reflecting the accelerating demand for accurate genetic analysis and personalized solutions, the industry is set for significant growth, reinforced by both technological advancements and the increasing emphasis on genomic-centric approaches in various fields.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Short Read Sequencing Market Technology Insights**

The Short Read Sequencing Market, focusing on the Technology segment, has shown significant growth trends, underpinned by innovations across various sequencing technologies. As per recent data, the market is expected to achieve a valuation of 7.71 USD Billion by 2024, highlighting its robust expansion. This segment includes prominent technologies like Illumina sequencing, Ion Torrent sequencing, SOLiD sequencing, and SMRT sequencing.

Illumina sequencing dominates the market due to its widespread adoption in clinical applications and Research and Development, thanks to its high throughput and accuracy.Ion Torrent sequencing is recognized for its rapid and cost-effective solutions, making it valuable in both research and diagnostic settings. Meanwhile, SOLiD sequencing, although less prevalent than others, is noted for its unique sequencing approach that ensures high fidelity, particularly in targeted resequencing studies. Finally, SMRT sequencing stands out for its capability of sequencing long reads, thus providing a fuller genomic picture.

The Short Read Sequencing Market is influenced by rising demand for genomic data, advancements in sequencing technology, and ongoing initiatives in personalized medicine, all contributing to its projected growth trajectory.

### **Short Read Sequencing Market End Use Insights**

The Short Read Sequencing Market, expected to achieve a valuation of 7.71 USD Billion in 2024, is witnessing significant growth driven by its application across various end-use sectors. Academic research institutes are essential as they leverage short read sequencing for groundbreaking discoveries in genomics and molecular biology, providing a foundation for further academic advancements. Pharmaceutical companies utilize this technology for drug development and personalized medicine, making it a pivotal component of R&D efforts.

Biotechnology companies are heavily invested in this market as they employ sequencing to innovate new therapies and products, showcasing its importance in bioproduct development.Meanwhile, hospitals and clinics incorporate short read sequencing for diagnostics and patient management, highlighting its practical implications in healthcare. The growing demand for precise genetic analysis and the surge in genomic studies and initiatives at the global level have spurred market growth. Overall, the Short Read Sequencing Market segmentation reflects a diversified range of applications, positioning it as a crucial tool in enhancing research, drug development, and clinical practices worldwide.

Market trends suggest increasing investment in these end-use segments, creating vast opportunities for advancements in genomics and personalized healthcare solutions across the globe.

### **Short Read Sequencing Market Product Type Insights**

The Short Read Sequencing Market is expected to experience substantial growth, with a projected valuation of 7.71 USD Billion in 2024. This market, driven by advancements in genomics and biotechnology, is witnessing an increasing demand for various product types essential for sequencing processes. Among these, sequencing kits, sequencing services, and sequencing instruments are critical components contributing to the market's expansion.

Sequencing kits are fundamental, providing researchers with the necessary tools to conduct genetic analyses, while sequencing services streamline the process for organizations lacking in-house capabilities, demonstrating significant reliance on outsourced solutions.Additionally, sequencing instruments are pivotal in enhancing accuracy and efficiency in sequencing operations, ensuring high-quality results that are essential in fields like clinical diagnostics and personalized medicine. As the Short Read Sequencing Market continues to evolve, navigating through developments, growth drivers, and challenges, the synergy between these product types remains significant for facilitating innovation and improving health outcomes globally.

Market growth is aligned with the increasing applications of sequencing technology, from basic research to clinical diagnostics, benefiting from supportive government initiatives promoting genomic research and healthcare advancements globally.

### **Short Read Sequencing Market Regional Insights**

The Regional analysis of the Short Read Sequencing Market reveals significant variations in growth and valuation across various areas, with North America demonstrating a strong market presence. Valued at 3.45 USD Billion in 2024, this region is expected to reach 8.8 USD Billion by 2035, indicating a substantial contribution to the overall market.

Europe holds a notable share as well, estimated at 2.25 USD Billion in 2024 and anticipated to grow to 5.7 USD Billion by 2035, driven by advanced Research and Development initiatives and strengthening healthcare infrastructures.In contrast, South America starts at a smaller base of 0.5 USD Billion in 2024, growing to 1.2 USD Billion by 2035, reflecting emerging opportunities in biotechnological applications. Asia Pacific captures attention with a valuation of 1.8 USD Billion in 2024, climbing to 4.5 USD Billion by 2035, signalling an expanding market bolstered by rising investment in genomics and personalized medicine.

The Middle East and Africa, starting at 0.71 USD Billion in 2024 and progressing to 1.8 USD Billion by 2035, represent growing sectors with increasing awareness and capabilities in genomics.This diverse geographical spread highlights crucial market growth drivers, such as heightened demand for genomic data, advancements in sequencing technologies, and a push towards personalized healthcare solutions.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Short Read Sequencing Market Key Players and Competitive Insights**

The Short Read Sequencing Market has witnessed significant growth and innovation, driven by advancements in sequencing technologies and increasing applications in genomics, personalized medicine, and genetic research. This market is characterized by a competitive landscape where various players are striving to gain a substantial share through the development of cutting-edge technologies and strategic collaborations. The significant demand from academic research centers, pharmaceutical companies, and biotechnology firms has intensified competition among key stakeholders. As the market evolves, players are focusing on enhancing the efficiency and accuracy of sequencing methods, reducing costs, and improving data analysis capabilities.

Emerging trends, such as the integration of artificial intelligence and machine learning in sequencing analysis, are also influencing the competitive dynamics within the market.Applied Biosystems has carved out a significant niche in the Short Read Sequencing Market with its focus on delivering high-throughput sequencing solutions that are widely utilized in academic, clinical, and industrial applications. The company's offerings include a range of sequencing instruments, platform solutions, and comprehensive support services designed to enhance the efficiency of sequencing workflows.

Applied Biosystems is known for its commitment to providing reliable and accurate results, which is pivotal for applications in genomics and personalized medicine. 

The company's strengths can be attributed to its extensive experience in the field, a robust product portfolio, and ongoing investments in research and development. Additionally, strategic mergers and acquisitions have enabled Applied Biosystems to expand its capabilities and enhance its market reach, allowing them to respond effectively to the evolving demands of the global market and solidify its position as a leader in the short read sequencing arena.

### **Key Companies in the Short Read Sequencing Market Include:**

- Applied Biosystems
- Element Biosciences
- Thermo Fisher Scientific
- PerkinElmer
- Agilent Technologies
- BGI
- Qiagen
- Illumina
- 10x Genomics
- BioRad Laboratories

## **Short Read Sequencing Market Industry Developments**

Recent developments in the Short Read Sequencing Market have shown significant advancements, with companies such as Illumina and Thermo Fisher Scientific pushing the boundaries through innovations in sequencing technologies. As of September 2023, Illumina's acquisition of Grail has been finalized, expanding its presence in the multi-cancer early detection space while enhancing its sequencing capabilities. 

BGI is also demonstrating growth, leveraging collaborations and partnerships to enhance their product offerings in short read sequencing. The global market is experiencing a surge in funding; for instance, Element Biosciences secured significant investment to enhance its engineering capabilities. Additionally, recent reports indicated that the market demand for short-read sequencing is expected to increase rapidly due to the expansion of applications across healthcare and environmental sectors. 

Over the past two years, various advancements in technology have decreased costs and improved accessibility, fostering further growth within this competitive landscape, and shaping the future of genomics worldwide.

## **Short Read Sequencing Market Segmentation Insights**

### Short Read Sequencing Market Application Outlook

- Clinical diagnostics
- Agrigenomics
- Oncology
- Genomics Research
- Molecular Biology

### **Short Read Sequencing Market Technology Outlook**

- Illumina sequencing
- Ion Torrent sequencing
- SOLiD sequencing
- SMRT sequencing

### **Short Read Sequencing Market End Use Outlook**

- Academic research institutes
- Pharmaceutical companies
- Biotechnology companies
- Hospitals and clinics

### **Short Read Sequencing Market Product Type Outlook**

- Sequencing kits
- Sequencing services
- Sequencing instruments

### **Short Read Sequencing Market Regional Outlook**

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### Rising Demand for Genomic Research

The Short Read Sequencing Market is witnessing a surge in demand for genomic research, fueled by the increasing prevalence of genetic disorders and the need for effective diagnostics. Researchers and healthcare providers are increasingly utilizing short read sequencing to identify genetic mutations and variations associated with various diseases. The market is expected to grow at a compound annual growth rate (CAGR) of approximately 15% over the next five years, reflecting the growing interest in genomics. This demand is further supported by government initiatives aimed at promoting genomic research and personalized medicine. Consequently, the Short Read Sequencing Market is likely to benefit from this heightened focus on genomic studies, leading to innovative applications in clinical settings.

### Technological Advancements in Sequencing

The Short Read Sequencing Market is experiencing rapid technological advancements that enhance sequencing capabilities. Innovations such as improved sequencing chemistries and advanced bioinformatics tools are driving efficiency and accuracy. For instance, the introduction of high-throughput sequencing platforms has significantly reduced the time required for genomic analysis. According to recent data, the market for sequencing technologies is projected to reach USD 10 billion by 2026, indicating a robust growth trajectory. These advancements not only facilitate faster data generation but also lower costs, making sequencing more accessible to researchers and clinicians alike. As a result, the Short Read Sequencing Market is poised for substantial expansion, driven by the continuous evolution of sequencing technologies.

### Growing Interest in Personalized Medicine

The Short Read Sequencing Market is increasingly influenced by the growing interest in personalized medicine, which tailors medical treatment to individual characteristics. As healthcare shifts towards more personalized approaches, the demand for sequencing technologies that can provide detailed genetic information is rising. This trend is evident in the increasing number of clinical trials and studies focusing on genomics and its applications in personalized therapies. Market analysts project that the personalized medicine segment within the Short Read Sequencing Market could reach USD 8 billion by 2027. This growth is indicative of the potential for sequencing technologies to play a pivotal role in developing targeted treatments, thereby enhancing patient outcomes.

### Collaborative Research and Funding Initiatives

The Short Read Sequencing Market is benefiting from collaborative research initiatives and increased funding from both public and private sectors. Partnerships between academic institutions, biotechnology companies, and government agencies are fostering innovation and accelerating research in genomics. These collaborations often lead to the development of new sequencing technologies and applications, enhancing the overall market landscape. Furthermore, funding initiatives aimed at supporting genomic research are on the rise, with several countries allocating substantial budgets for this purpose. This collaborative environment is expected to drive growth in the Short Read Sequencing Market, as it encourages knowledge sharing and resource pooling among stakeholders.

### Expansion of Applications in Clinical Diagnostics

The Short Read Sequencing Market is expanding its applications in clinical diagnostics, particularly in oncology and rare disease detection. The ability to accurately sequence DNA and RNA has revolutionized the way diseases are diagnosed and treated. For example, short read sequencing is increasingly used to identify specific mutations in cancer patients, enabling targeted therapies. The market for clinical diagnostics utilizing sequencing technologies is projected to grow significantly, with estimates suggesting a value of USD 5 billion by 2025. This expansion is indicative of the growing recognition of the importance of precision medicine. As a result, the Short Read Sequencing Market is likely to see increased investment and innovation in diagnostic applications.

## Future Outlook

The Short Read Sequencing Market is projected to grow at a 19.2% CAGR from 2025 to 2035, driven by advancements in technology, increasing demand for personalized medicine, and rising genomic research funding.

**New opportunities:**

- Development of portable sequencing devices for field research applications. Expansion of cloud-based data analysis platforms for genomic data. Partnerships with pharmaceutical companies for drug development using sequencing insights.

By 2035, the Short Read Sequencing Market is expected to be a pivotal component of genomic research and personalized healthcare.

## Segment Insights

### By Application: Clinical Diagnostics (Largest) vs. Oncology (Fastest-Growing)

In the Short Read Sequencing Market, [Clinical Diagnostics](https://www.marketresearchfuture.com/reports/clinical-diagnostic-market-41770) holds the largest share due to its pivotal role in disease identification and management. This segment benefits from increasing accuracy and efficiency in genetic testing, which has become a standard in medical diagnostics. Other significant segments include Agrigenomics and Moleculor Biology, which are shaped by advancements in technology and research capabilities, though they currently represent smaller market portions compared to Clinical Diagnostics.

Clinical Diagnostics (Dominant) vs. Oncology (Emerging)

The Clinical Diagnostics segment is characterized by its focus on utilizing short read sequencing for genetic testing, pathogen detection, and personalized medicine. As healthcare institutions adopt more advanced diagnostic strategies, the demand for high-throughput sequencing solutions has surged. In contrast, the Oncology segment is emerging rapidly, driven by a need for molecular profiling and targeted therapies. This sector thrives on innovation and is influenced by ongoing research to enhance cancer treatment outcomes, making it a vital area for future growth in the market.

### By Technology: Illumina Sequencing (Largest) vs. Ion Torrent Sequencing (Fastest-Growing)

In the Short Read Sequencing Market, Illumina sequencing holds the largest market share, solidifying its position as a leader due to its widespread adoption and reliable performance. This technology leverages sequencing by synthesis, allowing for high-throughput and cost-effective sequencing solutions, making it a preferred choice among researchers and clinicians. Conversely, Ion Torrent sequencing is gaining traction rapidly, known for its unique semiconductor technology that facilitates a faster sequencing process. It captures a growing share as researchers seek quicker results in genomics.

Sequencing Technology: Illumina (Dominant) vs. Ion Torrent (Emerging)

Illumina sequencing is recognized for its dominance in the Short Read Sequencing Market, characterized by high accuracy, vast scalability, and the capacity to generate massive amounts of data in a short time. Its robust technology is preferred for large-scale genomic studies and is often utilized in clinical applications. On the other hand, Ion Torrent sequencing represents an emerging force in the market. It offers a more compact and rapid sequencing option, appealing particularly for applications requiring fast turnaround times. As researchers and laboratories seek to enhance their sequencing capabilities, Ion Torrent's unique approach positions it well for future growth.

### By End Use: Academic Research Institutes (Largest) vs. Pharmaceutical Companies (Fastest-Growing)

The Short Read Sequencing Market shows a diverse distribution among its key end-use segments. Academic research institutes hold the largest market share, primarily due to their extensive utilization of sequencing technologies for genomics, transcriptomics, and various research projects. Following closely are pharmaceutical companies, which leverage short read sequencing for drug discovery and development. Biotechnology companies and hospitals/clinics also play significant roles, contributing to the overall landscape but holding smaller shares in comparison to the aforementioned segments. The growth trends in this segment are driven by advancements in sequencing technologies and an increasing focus on personalized medicine. Pharmaceutical companies are experiencing rapid growth as they adopt these technologies more extensively in R&D processes. Meanwhile, academic institutions continue to push the boundaries of genetic research, fueling market demand. The collaborative efforts between academia and industry further bolster this segment's dynamics, fostering innovation and applications across various domains.

Academic Research Institutes (Dominant) vs. Biotechnology Companies (Emerging)

Academic research institutes are positioned as the dominant force in the Short Read Sequencing Market. Their extensive funding, focus on cutting-edge research, and collaboration with key industry players contribute significantly to their influence. These institutions utilize short read sequencing not only for basic research but also for applications in fields such as bioinformatics, population genetics, and plant genomics. On the other hand, biotechnology companies represent an emerging segment. They are leveraging short read sequencing for innovative product development, including genetic therapies and diagnostics. The synergy between these companies and academic institutions is driving rapid advancements, potentially paving the way for new breakthroughs and applications in healthcare and agriculture sectors.

### By Product Type: Sequencing Kits (Largest) vs. Sequencing Services (Fastest-Growing)

In the Short Read Sequencing Market, sequencing kits hold the largest share, closely followed by sequencing services. [Sequencing kits](https://www.marketresearchfuture.com/reports/sequencing-kits-market-40130) are essential for conducting sequencing processes, and their established market position reflects the continuous demand for reliable and accurate genetic analysis tools. Conversely, sequencing services are gaining traction among laboratories and research institutions, increasing their footprint in the market.

Sequencing Kits (Dominant) vs. Sequencing Instruments (Emerging)

Sequencing kits are widely recognized for their critical role in the short read sequencing process, offering consistency and reliability that labs depend on for accurate results. These kits streamline workflow and enhance throughput, ensuring compatibility with various sequencing platforms. Meanwhile, sequencing instruments are emerging, with technological advancements making them more accessible. These instruments are designed for high-throughput environments, supporting increasingly complex sequencing tasks. As innovation continues, instruments are expected to adapt to new applications, thereby expanding their capabilities in both clinical and research settings.

## Regional Market Share Analysis

### North America : Innovation and Leadership Hub

North America is the largest market for short read sequencing, holding approximately 45% of the global market share. The region's growth is driven by advancements in genomics, increased funding for research, and a robust healthcare infrastructure. Regulatory support from agencies like the FDA and NIH further catalyzes innovation and adoption of sequencing technologies, enhancing research capabilities and clinical applications. The United States leads the market, with significant contributions from Canada. Key players such as Illumina, Thermo Fisher Scientific, and Pacific Biosciences dominate the landscape, fostering a competitive environment. The presence of numerous research institutions and universities accelerates the development and application of sequencing technologies, ensuring North America's continued leadership in the field.

### Europe : Growing Market with Regulations

Europe is the second-largest market for short read sequencing, accounting for approximately 30% of the global market share. The region benefits from strong regulatory frameworks and funding initiatives aimed at enhancing genomic research and healthcare applications. The European Union's Horizon 2020 program and various national initiatives promote innovation and collaboration among member states, driving demand for sequencing technologies. Leading countries include Germany, the UK, and France, with a competitive landscape featuring key players like Qiagen and Roche. The presence of advanced research facilities and a focus on personalized medicine further stimulate market growth. The European market is characterized by a mix of established companies and emerging startups, fostering a dynamic environment for innovation.

### Asia-Pacific : Emerging Market with Potential

Asia-Pacific is an emerging powerhouse in the short read sequencing market, holding approximately 20% of the global market share. The region's growth is driven by increasing investments in genomics, rising healthcare expenditures, and a growing emphasis on personalized medicine. Countries like China and India are witnessing rapid advancements in biotechnology, supported by government initiatives and funding aimed at enhancing research capabilities. China is the largest market in the region, with significant contributions from India and Japan. Key players such as BGI Genomics and Oxford Nanopore Technologies are expanding their presence, fostering competition and innovation. The region's diverse healthcare needs and expanding research infrastructure create a favorable environment for the adoption of sequencing technologies, positioning Asia-Pacific for substantial growth in the coming years.

### Middle East and Africa : Untapped Potential and Growth

The Middle East and Africa represent an emerging market for short read sequencing, accounting for approximately 5% of the global market share. The region is characterized by increasing investments in healthcare and biotechnology, driven by government initiatives aimed at improving healthcare infrastructure and research capabilities. The demand for genomic research is growing, particularly in countries like South Africa and the UAE, where there is a focus on personalized medicine and disease prevention. South Africa leads the market in the region, with a growing number of research institutions and collaborations enhancing the competitive landscape. The presence of international players is increasing, and local companies are emerging to meet the growing demand for sequencing technologies. As awareness of genomics expands, the Middle East and Africa are poised for significant growth in the short read sequencing market.

## Competitive Benchmarking

The Short Read Sequencing Market is characterized by a dynamic competitive landscape, driven by rapid technological advancements and increasing demand for genomic research. Key players such as Illumina (US), Thermo Fisher Scientific (US), and BGI Genomics (CN) are at the forefront, each adopting distinct strategies to enhance their market positioning. Illumina (US) continues to focus on innovation, particularly in developing next-generation sequencing technologies, while Thermo Fisher Scientific (US) emphasizes strategic partnerships to expand its product offerings. BGI Genomics (CN) is leveraging its cost-effective solutions to penetrate emerging markets, thereby shaping a competitive environment that is increasingly influenced by technological prowess and strategic collaborations. In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with a mix of established players and emerging companies vying for market share. The collective influence of these key players fosters a competitive atmosphere where innovation and strategic positioning are paramount. In August 2025, Illumina (US) announced a collaboration with a leading pharmaceutical company to develop a comprehensive genomic profiling platform aimed at accelerating drug discovery. This strategic move underscores Illumina's commitment to integrating genomic data into clinical applications, potentially revolutionizing personalized medicine and enhancing its competitive edge in the market. In September 2025, Thermo Fisher Scientific (US) launched a new line of sequencers designed for high-throughput applications, which could significantly reduce sequencing costs and time. This initiative not only strengthens Thermo Fisher's product portfolio but also positions the company as a leader in the high-throughput sequencing segment, catering to the growing demand for rapid genomic analysis. In July 2025, BGI Genomics (CN) expanded its operations into Southeast Asia by establishing a new facility in Singapore. This expansion is strategically significant as it allows BGI to tap into the burgeoning market for genomic research in the region, enhancing its global footprint and competitive positioning against Western counterparts. As of October 2025, the Short Read Sequencing Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence in sequencing technologies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, as companies strive to meet the growing demands of the genomic research community.

## Recent News & Developments

Recent developments in the Short Read Sequencing Market have shown significant advancements, with companies such as Illumina and Thermo Fisher Scientific pushing the boundaries through innovations in sequencing technologies. As of September 2023, Illumina's acquisition of Grail has been finalized, expanding its presence in the multi-cancer early detection space while enhancing its sequencing capabilities. 

BGI is also demonstrating growth, leveraging collaborations and partnerships to enhance their product offerings in short read sequencing. The global market is experiencing a surge in funding; for instance, Element Biosciences secured significant investment to enhance its engineering capabilities. Additionally, recent reports indicated that the market demand for short-read sequencing is expected to increase rapidly due to the expansion of applications across healthcare and environmental sectors. 

Over the past two years, various advancements in technology have decreased costs and improved accessibility, fostering further growth within this competitive landscape, and shaping the future of genomics worldwide.

## Report Scope

| MARKET SIZE 2024 | 9.485(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 11.31(USD Billion) |
| MARKET SIZE 2035 | 65.49(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 19.2% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Illumina (US), Thermo Fisher Scientific (US), BGI Genomics (CN), Roche (CH), Qiagen (DE), Oxford Nanopore Technologies (GB), Pacific Biosciences (US), Agilent Technologies (US), Genomatix (DE) |
| Segments Covered | Applications, Technology, End Use, Product Type, Regional |
| Key Market Opportunities | Advancements in bioinformatics tools enhance data analysis capabilities in the Short Read Sequencing Market. |
| Key Market Dynamics | Technological advancements drive competitive forces, enhancing efficiency and accuracy in the Short Read Sequencing Market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the projected market valuation of the Short Read Sequencing Market by 2035?**
A: The Short Read Sequencing Market is projected to reach a valuation of 65.49 USD Billion by 2035.

**Q: What was the market valuation of the Short Read Sequencing Market in 2024?**
A: In 2024, the market valuation of the Short Read Sequencing Market was 9.485 USD Billion.

**Q: What is the expected CAGR for the Short Read Sequencing Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Short Read Sequencing Market during the forecast period 2025 - 2035 is 19.2%.

**Q: Which application segment is projected to have the highest valuation by 2035?**
A: The Oncology application segment is projected to reach a valuation of 20.0 USD Billion by 2035.

**Q: What are the key players in the Short Read Sequencing Market?**
A: Key players in the Short Read Sequencing Market include Illumina, Thermo Fisher Scientific, BGI Genomics, Roche, and Qiagen.

**Q: How does the valuation of Illumina sequencing compare to other technologies by 2035?**
A: Illumina sequencing is projected to reach 30.0 USD Billion by 2035, making it the leading technology in the market.

**Q: What is the projected valuation for sequencing services by 2035?**
A: Sequencing services are projected to reach a valuation of 25.0 USD Billion by 2035.

**Q: Which end-use segment is expected to grow the most by 2035?**
A: Biotechnology companies are expected to grow the most, with a projected valuation of 25.0 USD Billion by 2035.

**Q: What is the expected valuation for sequencing kits by 2035?**
A: The expected valuation for sequencing kits by 2035 is 15.0 USD Billion.

**Q: How does the Short Read Sequencing Market's growth compare to other segments?**
A: The Short Read Sequencing Market's growth appears robust, with a projected increase from 9.485 USD Billion in 2024 to 65.49 USD Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/short-read-sequencing-market-21876*